secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xeris Biopharma Holdings, Inc. (XERS)
CIK:        0001867096
Form:       8-K
Filed at:   2022-01-03T23:59:59+00:00
Accession:  0001193125-22-000317
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Xeris Biopharma raises $30M in private placement with Armistice Capital
-----------------------------------------------------------------------

- Gross proceeds of $30M from sale of 10.2M shares at $2.93/share (closing price Dec 31, 2021).
- Warrants to purchase up to 5.1M shares at $3.223/share, exercisable immediately for 5 years.
- Net proceeds to support operations, commercial products, clinical trials, working capital.
- Private placement expected to close Jan 3, 2022; resale registration statement to be filed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1867096/000119312522000317/0001193125-22-000317-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1867096/000119312522000317/d221763d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-000317

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer